154 related articles for article (PubMed ID: 24504151)
1. Southern African Treatment Resistance Network (SATuRN) RegaDB HIV drug resistance and clinical management database: supporting patient management, surveillance and research in southern Africa.
Manasa J; Lessells R; Rossouw T; Naidu K; Van Vuuren C; Goedhals D; van Zyl G; Bester A; Skingsley A; Stott K; Danaviah S; Chetty T; Singh L; Moodley P; Iwuji C; McGrath N; Seebregts CJ; de Oliveira T
Database (Oxford); 2014; 2014():bat082. PubMed ID: 24504151
[TBL] [Abstract][Full Text] [Related]
2. High-levels of acquired drug resistance in adult patients failing first-line antiretroviral therapy in a rural HIV treatment programme in KwaZulu-Natal, South Africa.
Manasa J; Lessells RJ; Skingsley A; Naidu KK; Newell ML; McGrath N; de Oliveira T;
PLoS One; 2013; 8(8):e72152. PubMed ID: 23991055
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 subtypes B and C unique recombinant forms (URFs) and transmitted drug resistance identified in the Western Cape Province, South Africa.
Jacobs GB; Wilkinson E; Isaacs S; Spies G; de Oliveira T; Seedat S; Engelbrecht S
PLoS One; 2014; 9(6):e90845. PubMed ID: 24609015
[TBL] [Abstract][Full Text] [Related]
4. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
5. [Status of resistance of HIV-1 strains in Africa: what is the role of viral surveillance networks?].
Grandadam M; Nicand E; Koeck JL; Caron M; Teyssou R
Med Trop (Mars); 2002; 62(1):89-93. PubMed ID: 12038188
[TBL] [Abstract][Full Text] [Related]
6. Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study.
Drescher SM; von Wyl V; Yang WL; Böni J; Yerly S; Shah C; Aubert V; Klimkait T; Taffé P; Furrer H; Battegay M; Ambrosioni J; Cavassini M; Bernasconi E; Vernazza PL; Ledergerber B; Günthard HF; Kouyos RD;
Clin Infect Dis; 2014 Jan; 58(2):285-94. PubMed ID: 24145874
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa.
Marconi VC; Sunpath H; Lu Z; Gordon M; Koranteng-Apeagyei K; Hampton J; Carpenter S; Giddy J; Ross D; Holst H; Losina E; Walker BD; Kuritzkes DR;
Clin Infect Dis; 2008 May; 46(10):1589-97. PubMed ID: 18419495
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study.
Hamers RL; Wallis CL; Kityo C; Siwale M; Mandaliya K; Conradie F; Botes ME; Wellington M; Osibogun A; Sigaloff KC; Nankya I; Schuurman R; Wit FW; Stevens WS; van Vugt M; de Wit TF;
Lancet Infect Dis; 2011 Oct; 11(10):750-9. PubMed ID: 21802367
[TBL] [Abstract][Full Text] [Related]
9. Rationale and uses of a public HIV drug-resistance database.
Shafer RW
J Infect Dis; 2006 Sep; 194 Suppl 1(Suppl 1):S51-8. PubMed ID: 16921473
[TBL] [Abstract][Full Text] [Related]
10. Transmission patterns of HIV-subtypes A/AE versus B: inferring risk-behavior trends and treatment-efficacy limitations from viral genotypic data obtained prior to and during antiretroviral therapy.
Avidor B; Turner D; Mor Z; Chalom S; Riesenberg K; Shahar E; Pollack S; Elbirt D; Sthoeger Z; Maayan S; Olshtain-Pops K; Averbuch D; Chowers M; Istomin V; Anis E; Mendelson E; Ram D; Levy I; Grossman Z
PLoS One; 2013; 8(3):e57789. PubMed ID: 23469241
[TBL] [Abstract][Full Text] [Related]
11. Implementing HIV-1 genotypic resistance testing in antiretroviral therapy programs in Africa: needs, opportunities, and challenges.
Lessells RJ; Avalos A; de Oliveira T
AIDS Rev; 2013; 15(4):221-9. PubMed ID: 24322382
[TBL] [Abstract][Full Text] [Related]
12. Primary drug resistance in South Africa: data from 10 years of surveys.
Manasa J; Katzenstein D; Cassol S; Newell ML; de Oliveira T;
AIDS Res Hum Retroviruses; 2012 Jun; 28(6):558-65. PubMed ID: 22251009
[TBL] [Abstract][Full Text] [Related]
13. Moderate Levels of Pre-Treatment HIV-1 Antiretroviral Drug Resistance Detected in the First South African National Survey.
Steegen K; Carmona S; Bronze M; Papathanasopoulos MA; van Zyl G; Goedhals D; MacLeod W; Sanne I; Stevens WS
PLoS One; 2016; 11(12):e0166305. PubMed ID: 27907009
[TBL] [Abstract][Full Text] [Related]
14. Surveillance of HIV-1 pol transmitted drug resistance in acutely and recently infected antiretroviral drug-naïve persons in rural western Kenya.
Onywera H; Maman D; Inzaule S; Auma E; Were K; Fredrick H; Owiti P; Opollo V; Etard JF; Mukui I; Kim AA; Zeh C
PLoS One; 2017; 12(2):e0171124. PubMed ID: 28178281
[TBL] [Abstract][Full Text] [Related]
15. Trends in Drug Resistance Prevalence, HIV-1 Variants and Clinical Status in HIV-1-infected Pediatric Population in Madrid: 1993 to 2015 Analysis.
Rojas Sánchez P; Domínguez S; Jiménez De Ory S; Prieto L; Rojo P; Mellado P; Navarro M; Delgado R; Ramos JT; Holguín Á;
Pediatr Infect Dis J; 2018 Mar; 37(3):e48-e57. PubMed ID: 28991889
[TBL] [Abstract][Full Text] [Related]
16. Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study.
Inzaule SC; Hamers RL; Noguera-Julian M; Casadellà M; Parera M; Kityo C; Steegen K; Naniche D; Clotet B; Rinke de Wit TF; Paredes R;
Lancet HIV; 2018 Nov; 5(11):e638-e646. PubMed ID: 30282603
[TBL] [Abstract][Full Text] [Related]
17. Bridging the gap between HIV epidemiology and antiretroviral resistance evolution: Modelling the spread of resistance in South Africa.
Hauser A; Kusejko K; Johnson LF; Wandeler G; Riou J; Goldstein F; Egger M; Kouyos RD
PLoS Comput Biol; 2019 Jun; 15(6):e1007083. PubMed ID: 31233494
[TBL] [Abstract][Full Text] [Related]
18. HIV type-1 drug resistance in antiretroviral treatment-naive adults infected with non-B subtype virus in the United Kingdom.
Chilton DN; Castro H; Lattimore S; Harrison LJ; Fearnhill E; Delpech V; Rice B; Pillay D; Dunn DT;
Antivir Ther; 2010; 15(7):985-91. PubMed ID: 21041913
[TBL] [Abstract][Full Text] [Related]
19. Update on HIV-1 acquired and transmitted drug resistance in Africa.
Ssemwanga D; Lihana RW; Ugoji C; Abimiku A; Nkengasong J; Dakum P; Ndembi N
AIDS Rev; 2015; 17(1):3-20. PubMed ID: 25427100
[TBL] [Abstract][Full Text] [Related]
20. Low rates of nucleoside reverse transcriptase inhibitor resistance in a well-monitored cohort in South Africa on antiretroviral therapy.
Wallis CL; Papathanasopolous MA; Fox M; Conradie F; Ive P; Orrell C; Zeinecker J; Sanne I; Wood R; McIntyre J; Stevens W;
Antivir Ther; 2012; 17(2):313-20. PubMed ID: 22293461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
